Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals

Published date11 February 2019
Citation84 FR 3191
Record Number2019-01812
SectionNotices
CourtFood And Drug Administration,Health And Human Services Department
Federal Register, Volume 84 Issue 28 (Monday, February 11, 2019)
[Federal Register Volume 84, Number 28 (Monday, February 11, 2019)]
                [Notices]
                [Pages 3191-3192]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-01812]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Food and Drug Administration
                [Docket Nos. FDA-2012-N-0438; FDA-2018-D-1592; FDA-2014-D-2138; FDA-
                2018-N-0180; FDA-2014-N-1960; FDA-2015-N-1837; and FDA-2016-D-4308]
                Agency Information Collection Activities; Announcement of Office
                of Management and Budget Approvals
                AGENCY: Food and Drug Administration, HHS.
                ACTION: Notice.
                -----------------------------------------------------------------------
                SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
                information collections that have been approved by the Office of
                Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
                FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
                Food and Drug Administration, Three White Flint North, 10A-12M, 11601
                Landsdown St., North Bethesda, MD 20852, 301-796-7726,
                PRAStaff@fda.hhs.gov.
                SUPPLEMENTARY INFORMATION: The following is a list of FDA information
                collections recently approved by OMB under section 3507 of the
                Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
                number and expiration date of OMB approval for each information
                collection are shown in table 1. Copies of the supporting statements
                for the information collections are available on the internet at
                https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
                sponsor, and a person is not required to respond to, a collection of
                [[Page 3192]]
                information unless it displays a currently valid OMB control number.
                 Table 1--List of Information Collections Approved by OMB
                ------------------------------------------------------------------------
                 OMB Control Date approval
                 Title of collection No. expires
                ------------------------------------------------------------------------
                Recommendations for Early Food Safety 0910-0583 10/31/2021
                 Evaluation of New Non-Pesticidal
                 Proteins Produced by New Plant
                 Varieties Intended for Food Use........
                Guidance for Industry on Controlled 0910-0797 10/31/2021
                 Correspondence Related to Generic Drug
                 Development............................
                Guidance for Industry on Adverse Event 0910-0800 10/31/2021
                 Reporting for Outsourcing Facilities
                 Under Section 503B of the Federal Food,
                 Drug, and Cosmetic Act.................
                Generic Clearance for the Collection of 0910-0810 10/31/2021
                 Quantitative Data on Tobacco Products
                 and Communications.....................
                MedWatch: Adverse Event and Product 0910-0291 11/30/2021
                 Experience Reporting System (Paper-
                 Based).................................
                Electronic User Fee Payment Form 0910-0805 11/30/2021
                 Requests...............................
                Labeling of Red Blood Cell Units with 0910-0862 11/30/2021
                 Historical Antigen Typing Results......
                Postmarketing Adverse Drug Experience 0910-0230 12/31/2021
                 Reporting..............................
                ------------------------------------------------------------------------
                 Dated: February 5, 2019.
                Lowell J. Schiller,
                Acting Associate Commissioner for Policy.
                [FR Doc. 2019-01812 Filed 2-8-19; 8:45 am]
                 BILLING CODE 4164-01-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT